Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022)
Zimmer Biomet Holdings' (ZBH) quarterly Notes Payables came in at $83.0 million in Q4 2022, up 39.97% quarter-over-quarter from $59.3 million in Q4 2014.
Zimmer Biomet Holdings (ZBH) Notes Payables (2011 - 2022) Analysis & Trends
Zimmer Biomet Holdings' Notes Payables history runs 5 years deep, the most recent figure standing at $83.0 million for Q4 2022.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $83.0 million in Q4 2022; TTM through Dec 2022 was $83.0 million, a N/A change from a year earlier, with the FY2022 full-year figure at $83.0 million, changed N/A from the prior year.
- Notes Payables advanced to $83.0 million in Q4 2022 per ZBH's latest filing, from $59.3 million in the prior quarter.
- Across five years, Notes Payables topped out at $83.0 million in Q4 2022 and bottomed at $83.0 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 83.00 Mn |
| Dec 31, 2014 | 59.30 Mn |
| Dec 31, 2013 | 500,000.00 |
| Dec 31, 2012 | 100,000.00 |
| Sep 30, 2012 | 300,000.00 |
| Jun 30, 2012 | 3.40 Mn |
| Mar 31, 2012 | 144.60 Mn |
| Dec 31, 2011 | 143.30 Mn |